Enterprise Value
13.98M
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.51%
Insider Ownership
1.04%
Institutional Own.
2.27%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sulopenem Details Urinary tract infection | Phase 3 Interim Update | |
Sulopenem Details Intra-abdominal infections | Failed Discontinued | |
Sulopenem Details Urinary tract infection | Failed Discontinued |